Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke

Title
Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke
Authors
Keywords
-
Journal
STROKE
Volume 45, Issue 11, Pages 3304-3310
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-10-01
DOI
10.1161/strokeaha.114.005835

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now